Medicare Enrolled
Dr. John Watson, MD
Urology Physician · Columbus, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Watson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Watson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Watson
Dr. John Watson is an urology physician in Columbus, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Watson performed 12,703 Medicare services across 1,906 unique beneficiaries.
Between the years covered by Open Payments, Dr. Watson received a total of $4,198 from 37 pharmaceutical and/or device companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Watson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 6% volume in NJ
$4,198 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,703
Medicare services
Top 6% in NJ for urology physician
1,906
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~706 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 7,440 | $3 | $7 |
| BCG treatment for bladder cancer | 2,350 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
721 | $96 | $274 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
573 | $68 | $188 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
250 | $10 | $319 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 165 | $129 | $423 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
147 | $39 | $168 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
129 | $27 | $121 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
126 | $8 | $15 |
| PSA test (prostate cancer screening) | 124 | $18 | $76 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $131 | $412 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
66 | $206 | $890 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
62 | $18 | $76 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
52 | $75 | $1,459 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $140 | $497 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
30 | $8 | $33 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
30 | $8 | $34 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
28 | $340 | $1,861 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
28 | $172 | $1,275 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
28 | $49 | $206 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
27 | $28 | $595 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $142 | $366 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
25 | $5 | $21 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
25 | $4 | $17 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
19 | $25 | $106 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
18 | $179 | $1,443 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
18 | $8 | $13 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
17 | $8 | $33 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
14 | $8 | $35 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
13 | $8 | $32 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
13 | $275 | $2,105 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
12 | $124 | $766 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,198
Total received (2018-2024)
Avg $600/year across 7 years
Top 32% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
261
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,198 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$49
2023
$31
2022
$197
2021
$1,344
2020
$885
2019
$953
2018
$739
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$33
UROGEN PHARMA, INC.
$16
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$569
PFIZER INC.
$408
Dendreon Pharmaceuticals LLC
$316
AbbVie Inc.
$303
Janssen Biotech, Inc.
$266
Bayer HealthCare Pharmaceuticals Inc.
$251
Antares Pharma, Inc.
$211
Myriad Genetic Laboratories, Inc.
$182
Endo Pharmaceuticals Inc.
$166
Stryker Corporation
$138
180 Medical, Inc.
$119
Amgen Inc.
$114
TOLMAR Pharmaceuticals, Inc.
$109
NeoTract Inc.
$93
Myovant Sciences Inc.
$87
Avadel Specialty Pharmaceuticals, LLC
$67
Allergan, Inc.
$65
Merck Sharp & Dohme Corporation
$58
AbbVie, Inc.
$57
Clarus Therapeutics Inc.
$57
Acerus Pharmaceuticals Corporation
$54
AstraZeneca Pharmaceuticals LP
$52
Ambu Inc.
$48
Boston Scientific Corporation
$47
UROVANT SCIENCES INC
$42
PROCEPT BioRobotics Corporation
$42
Ferring Pharmaceuticals Inc.
$41
Allergan Inc.
$37
Photocure Inc
$36
Teleflex LLC
$29
ABBVIE INC.
$28
Blue Earth Diagnostics Limited
$26
Axonics, Inc.
$19
UROGEN PHARMA, INC.
$16
Verity Pharmaceuticals Inc.
$15
Foundation Medicine, Inc.
$15
Medtronic USA, Inc.
$12
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
AMS · AQUABEAM ROBOTIC SYSTEM · ASNIS · Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PROVENGE · Prolaris · Prolia · REZUM · TOVIAZ · Trelstar · UroLift · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
207
Per 100K population
44.6
County median income
$105,271
Nearest hospital
VIRTUA MOUNT HOLLY HOSPITAL
6.1 mi
6.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Watson is a mixed practice specialist, with above-average Medicare volume (top 6% in NJ), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Watson experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Watson performed 7,440 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Watson receive payments from pharmaceutical companies?
Yes. Dr. Watson received a total of $4,198 from 37 companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Watson's costs compare to other urology physicians in Columbus?
Dr. Watson's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Watson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Columbus
Browse urology physicians in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology